alexa Bororetinoids As Potential Therapeutics For Treatment Of Glioblastoma | 10577
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing

Bhaskar C. Das
Accepted Abstracts: Med chem
DOI: 10.4172/2161-0444.S1.009
Abstract
Glioblastoma multiforme (GBM), also simply called glioblastoma, is the most aggressive primary brain tumor in adults with two-year survival rate of 28% following surgical resection, chemotherapy, and radiotherapy. Recurrence of gliobalstoma is nearly certain after initial treatment and there is currently no therapy proven to prolong the survival of the patients after tumor recurrence. Thus, there is a desperate need for new and improved therapies to combat growth and regrowth of GBM. Retinoic acid (RA) signaling pathways regulate GBM stem cell biology, RA is used as chemotherapeutic agent, and also RA based therapeutic agents penetrate blood-brain-barrier (BBB). RAs are a class of natural and synthetic vitamin A analogues that play a central role in the control of cell growth and differentiation of normal and malignant cell types. Thus, retinoid therapy has the potential to impact a wide array of disorders. Given the long history of research and major strides in understanding retinoid biology, it is somewhat surprising and certainly frustrating that better probes and drugs are not available due to toxicity and lack of specificity of the compounds to receptors. To address this issue, we have develop new chemistry to generate small libraries of boron-containing retinoids and test their activity via reporter cell, whole animal, and embryonic stem cell based assays and tested their anti-cancer mechanisms in different human glioblastoma cells lines. The overall goal of our program is to develop retinoid based multifunctional therapeutic agents in other words ?single drug multitarget?, which will be useful not only to inhibits tumor cells, but also will protect normal central nervous system (CNS) cells.
Biography
Bhaskar C. Das has completed his Ph.D. at the age of 28 years from Indian Institute of Technology (IIT), Kanpur (India) and postdoctoral studies from UTK, Harvard Medical School and MIT. He is the Associate Professor of Internal Medicine of the University of Kansas Medical Center, a premier bio- medical organization. He has published more than 50 papers in reputed journals and holds 12 patents. He is serving as an editorial board member of repute and member of many national and international scientific organizations and scientific reviewer of many funding agencies.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

bornova escort

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version